For: | Moehler M, Lyros O, Gockel I, Galle PR, Lang H. Multidisciplinary management of gastric and gastroesophageal cancers. World J Gastroenterol 2008; 14(24): 3773-3780 [PMID: 18609699 DOI: 10.3748/wjg.14.3773] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v14/i24/3773.htm |
Number | Citing Articles |
1 |
Zhang Hui, Meng Xianglin. Association of HOTAIR expression with PI3K/Akt pathway activation in adenocarcinoma of esophagogastric junction. Open Medicine 2016; 11(1): 36 doi: 10.1515/med-2016-0008
|
2 |
Zongtai Li, Xiaofang Zou, Liangxi Xie, Hongmei Dong, Yuping Chen, Qing Liu, Xiao Wu, David Zhou, Dongfeng Tan, Hao Zhang, Nikki Pui-yue Lee. Prognostic Importance and Therapeutic Implications of PAK1, a Drugable Protein Kinase, in Gastroesophageal Junction Adenocarcinoma. PLoS ONE 2013; 8(11): e80665 doi: 10.1371/journal.pone.0080665
|
3 |
Richard M. Gore, Jung Hoon Kim, Chiao-Yun Chen. Gastric Cancer. 2009; : 120 doi: 10.1017/CBO9780511691751.009
|
4 |
Christoph Schulz, Frank Kullmann, Volker Kunzmann, Martin Fuchs, Michael Geissler, Ursula Vehling-Kaiser, Heribert Stauder, Axel Wein, Salah-Eddin Al-Batran, Thomas Kubin, Claus Schäfer, Sebastian Stintzing, Clemens Giessen, Dominik Paul Modest, Karsten Ridwelski, Volker Heinemann. NeoFLOT: Multicenter phase II study of perioperative chemotherapy in resectable adenocarcinoma of the gastroesophageal junction or gastric adenocarcinoma-Very good response predominantly in patients with intestinal type tumors. International Journal of Cancer 2015; 137(3): 678 doi: 10.1002/ijc.29403
|
5 |
Francesco Cellini, Calogero Casà, Andrea D’Aviero, Vincenzo Valentini. Target Volume Definition in Radiation Oncology. 2023; : 177 doi: 10.1007/978-3-031-45489-9_8
|
6 |
Amy T. Y. Chang, Wai Tong Ng, Ada L. Y. Law, Ki Man Ku, Michael C. H. Lee, Anne W. M. Lee. Adjuvant chemoradiation for resected gastric cancer: a 10-year experience. Gastric Cancer 2011; 14(1): 63 doi: 10.1007/s10120-011-0011-y
|
7 |
Yan Yi, Jinming Yu, Baosheng Li, Fujun Yang, Wei Huang, Hongfu Sun, Heyi Gong, Tao Zhou, Haiqun Lin. Pattern of lymph node metastases and its implication in radiotherapeutic clinical target volume delineation of regional lymph node in patients with gastric carcinoma. Radiotherapy and Oncology 2010; 96(2): 223 doi: 10.1016/j.radonc.2010.04.031
|
8 |
B. R. Mittal, Rahul Parghane, J. Mohan Roop. Positron Emission Tomography. 2015; : 113 doi: 10.1007/978-81-322-2098-5_13
|
9 |
Hong Ma, Jun Han, Tao Zhang, Yang Ke. Comparison of dosiology between three dimensional conformal and intensity-modulated radiotherapies (5 and 7 fields) in gastric cancer post-surgery. Journal of Huazhong University of Science and Technology [Medical Sciences] 2013; 33(5): 759 doi: 10.1007/s11596-013-1193-9
|
10 |
Wenzhe Kang, Hongmei Zeng, Jianping Xiong, Yang Li, Peng Jin, Xinxin Shao, Haitao Hu, Bingzhi Wang, Yibin Xie, Yantao Tian. Survival of patients with gastric cancer surgically treated at the National Cancer Center of China from 2011 to 2018 according to stage at diagnosis. Journal of the National Cancer Center 2022; 2(3): 132 doi: 10.1016/j.jncc.2022.07.002
|
11 |
J. Arredondo, C. Pastor, J. Baixauli, J. Rodríguez, I. González, C. Vigil, A. Chopitea, J. L. Hernández‐Lizoáin. Preliminary outcome of a treatment strategy based on perioperative chemotherapy and surgery in patients with locally advanced colon cancer. Colorectal Disease 2013; 15(5): 552 doi: 10.1111/codi.12119
|
12 |
Zongtai Li, Xiaofang Zou, Liangxi Xie, Hongcai Chen, Yuping Chen, Sai‐Ching Jim Yeung, Hao Zhang. Personalizing risk stratification by addition of PAK1 expression to TNM staging: Improving the accuracy of clinical decision for gastroesophageal junction adenocarcinoma. International Journal of Cancer 2015; 136(7): 1636 doi: 10.1002/ijc.29167
|
13 |
Jean M. Butte, Enrique Waugh, Hugo Parada, Hernán De La Fuente. Combined total gastrectomy, total esophagectomy, and D2 lymph node dissection with transverse colonic interposition for adenocarcinoma of the gastroesophageal junction. Surgery Today 2011; 41(9): 1319 doi: 10.1007/s00595-010-4412-z
|
14 |
Jamie D. Croxtall, Kate McKeage. Trastuzumab in HER2-Positive Metastatic Gastric Cancer†. BioDrugs 2011; 25(4): 257 doi: 10.2165/11207110-000000000-00000
|
15 |
Hongmei Dong, Hong Guo, Liangxi Xie, Geng Wang, Xueyun Zhong, Thaer Khoury, Dongfeng Tan, Hao Zhang, Anthony WI. Lo. The Metastasis-Associated Gene MTA3, a Component of the Mi-2/NuRD Transcriptional Repression Complex, Predicts Prognosis of Gastroesophageal Junction Adenocarcinoma. PLoS ONE 2013; 8(5): e62986 doi: 10.1371/journal.pone.0062986
|
16 |
Hua Zhao, Yongli Fan, Hui Li, Jinpu Yu, Liang Liu, Shui Cao, Baozhu Ren, Fang Yan, Xiubao Ren. Immunotherapy with Cytokine-Induced Killer Cells as an Adjuvant Treatment for Advanced Gastric Carcinoma: A Retrospective Study of 165 Patients. Cancer Biotherapy and Radiopharmaceuticals 2013; 28(4): 303 doi: 10.1089/cbr.2012.1306
|
17 |
Armin Wiegering, Meik Kunz, Mohamed Hussein, Ingo Klein, Verena Wiegering, Friedrich Wilhelm Uthe, Ulrich A. Dietz, Christian Jurowich, Thorsten Bley, Thomas Dandekar, Christoph-Thomas Germer, Christian Ritter. Diagnostic value of preoperative CT scan to stratify colon cancer for neoadjuvant therapy. International Journal of Colorectal Disease 2015; 30(8): 1067 doi: 10.1007/s00384-015-2265-z
|
18 |
Mario Scartozzi, Walter Siquini, Elena Maccaroni, Maristella Bianconi, Riccardo Giampieri, Rossana Berardi, Stefano Cascinu. Surgery in the Multimodal Management of Gastric Cancer. 2012; : 187 doi: 10.1007/978-88-470-2318-5_24
|
19 |
Massimo Bellini, Dario Gambaccini, Gabrio Bassotti. Comorbidities in functional gastrointestinal diseases: Do we need a lone ranger or a dream team?. Digestive and Liver Disease 2016; 48(5): 562 doi: 10.1016/j.dld.2016.02.011
|
20 |
Oscar Matzinger, Erich Gerber, Zvi Bernstein, Philippe Maingon, Karin Haustermans, Jean François Bosset, Akos Gulyban, Philip Poortmans, Laurence Collette, Abraham Kuten. EORTC-ROG expert opinion: Radiotherapy volume and treatment guidelines for neoadjuvant radiation of adenocarcinomas of the gastroesophageal junction and the stomach. Radiotherapy and Oncology 2009; 92(2): 164 doi: 10.1016/j.radonc.2009.03.018
|
21 |
J. Arredondo, E. Pastor, V. Simó, M. Beltrán, C. Castañón, M. C. Magdaleno, I. Matanza, M. Notarnicola, B. Ielpo. Neoadjuvant chemotherapy in locally advanced colon cancer: a systematic review. Techniques in Coloproctology 2020; 24(10): 1001 doi: 10.1007/s10151-020-02289-4
|
22 |
Gianluca Tomasello, Matteo Dalla Chiesa, Sebastiano Buti, Matteo Brighenti, Federica Negri, Rodrigo Kraft Rovere, Mario Martinotti, Massimo Buononato, Antonio Brunelli, Silvia Lazzarelli, Gianvito Donati, Rodolfo Passalacqua. Dose-dense Chemotherapy in Metastatic Gastric Cancer with a Modified Docetaxel-Cisplatin-5-Fluorouracil Regimen. Tumori Journal 2010; 96(1): 48 doi: 10.1177/030089161009600108
|
23 |
Linda Agolli, Luca Nicosia. Between evidence and new perspectives on the current state of the multimodal approach to gastric cancer: Is there still a role for radiation therapy?. World Journal of Gastrointestinal Oncology 2018; 10(9): 271-281 doi: 10.4251/wjgo.v10.i9.271
|
24 |
Yeon Jin Kim, Jaeseung Lim, Jong Soon Kang, Hwan Mook Kim, Hong Kyung Lee, Hwa Sun Ryu, Jee Youn Kim, Jin Tae Hong, Youngsoo Kim, Sang-Bae Han. Adoptive immunotherapy of human gastric cancer with ex vivo expanded T cells. Archives of Pharmacal Research 2010; 33(11): 1789 doi: 10.1007/s12272-010-1111-7
|
25 |
H. Dong, L. Xie, C. Tang, S. Chen, Q. Liu, Q. Zhang, W. Zheng, Z. Zheng, H. Zhang. Snail1 correlates with patient outcomes in E-cadherin-preserved gastroesophageal junction adenocarcinoma. Clinical and Translational Oncology 2014; 16(9): 783 doi: 10.1007/s12094-013-1149-3
|
26 |
B. Xiong, L. Ma, Y. Cheng, C. Zhang. RETRACTED: Clinical effectiveness of neoadjuvant chemotherapy in advanced gastric cancer: An updated meta-analysis of randomized controlled trials. European Journal of Surgical Oncology (EJSO) 2014; 40(10): 1321 doi: 10.1016/j.ejso.2014.01.006
|
27 |
Dong Shen, Zhi-Hao Liu, Jia-Ning Xu, Fang Xu, Qin-Feng Lin, Feng Lin, Wei-Dong Mao. Efficacy of Adoptive Cellular Therapy in Patients With Gastric Cancer: A Meta-Analysis. Immunotherapy 2016; 8(8): 971 doi: 10.2217/imt.16.10
|
28 |
Sanchuan Lai, Tingting Su, Xingkang He, Zhenghua Lin, Shujie Chen. Prognostic value of resected lymph nodes numbers for Siewert II gastroesophageal junction cancer. Oncotarget 2018; 9(2): 2797 doi: 10.18632/oncotarget.23540
|
29 |
Binghong Xiong, Li Ma, Wei Huang, Yong Cheng, Qikang Zhao, Jingshan Liu. WITHDRAWN: Clinical effectiveness of neoadjuvant chemotherapy in advanced gastric cancer: An updated meta-analysis of 12 randomized controlled trials. Surgical Oncology 2014; doi: 10.1016/j.suronc.2014.11.005
|
30 |
Shuhang Xu, Lingling Feng, Yongming Chen, Ying Sun, Yao Lu, Shaomin Huang, Yang Fu, Rongqin Zheng, Yujing Zhang, Rong Zhang. Consistency mapping of 16 lymph node stations in gastric cancer by CT-based vessel-guided delineation of 255 patients. Oncotarget 2017; 8(25): 41465 doi: 10.18632/oncotarget.18407
|
31 |
Jeremy J. Erasmus, Eric M. Rohren, Roland Hustinx. PET and PET/CT in the Diagnosis and Staging of Esophageal and Gastric Cancers. PET Clinics 2008; 3(2): 135 doi: 10.1016/j.cpet.2008.09.002
|
32 |
Jamie D. Croxtall, Kate McKeage. Trastuzumab. Drugs 2010; 70(17): 2259 doi: 10.2165/11205900-000000000-00000
|
33 |
Christopher Ganser, Eva Lauermann, Annett Maderer, Torsten Stauder, Jan-Peter Kramb, Stanislav Plutizki, Thomas Kindler, Markus Moehler, Gerd Dannhardt. Novel 3-Azaindolyl-4-arylmaleimides Exhibiting Potent Antiangiogenic Efficacy, Protein Kinase Inhibition, and Antiproliferative Activity. Journal of Medicinal Chemistry 2012; 55(22): 9531 doi: 10.1021/jm301217c
|
34 |
Linda Agolli, Riccardo Maurizi Enrici, Mattia Falchetto Osti. Adjuvant radiochemotherapy for gastric cancer: Should we use prognostic factors to select patients?. World Journal of Gastroenterology 2016; 22(3): 1131-1138 doi: 10.3748/wjg.v22.i3.1131
|